These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21968782)

  • 1. Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions.
    Chen PL; Cole SR; Morrison CS
    Epidemiology; 2011 Nov; 22(6):877-8. PubMed ID: 21968782
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition.
    Morrison CS; Richardson BA; Celentano DD; Chipato T; Mmiro F; Mugerwa R; Padian NS; Rugpao S; Salata RA
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S17-8. PubMed ID: 15867602
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
    Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
    J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.
    Morrison CS; Chen PL; Kwok C; Richardson BA; Chipato T; Mugerwa R; Byamugisha J; Padian N; Celentano DD; Salata RA
    AIDS; 2010 Jul; 24(11):1778-81. PubMed ID: 20588106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.
    Richardson BA; Otieno PA; Mbori-Ngacha D; Overbaugh J; Farquhar C; John-Stewart GC
    AIDS; 2007 Mar; 21(6):749-53. PubMed ID: 17413696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    Levine JP
    J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
    [No Abstract]   [Full Text] [Related]  

  • 7. End of the debate on hormonal contraception and HIV risk?
    Lancet Infect Dis; 2015 Feb; 15(2):131. PubMed ID: 25749056
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exogenous hormones.
    McClelland RS
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S38-9. PubMed ID: 15867617
    [No Abstract]   [Full Text] [Related]  

  • 10. Broadening the debate over HIV and hormonal contraception.
    Colvin CJ; Harrison A
    Lancet Infect Dis; 2015 Feb; 15(2):135-6. PubMed ID: 25578824
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next steps for research on hormonal contraception and HIV.
    Ralph LJ; McCoy SI; Hallett T; Padian N
    Lancet; 2013 Nov; 382(9903):1467-9. PubMed ID: 23810224
    [No Abstract]   [Full Text] [Related]  

  • 13. Research on hormonal contraception and HIV.
    Redd AD
    Lancet; 2014 Jan; 383(9914):305. PubMed ID: 24461118
    [No Abstract]   [Full Text] [Related]  

  • 14. Research on hormonal contraception and HIV.
    Gollub EL; Stein Z
    Lancet; 2014 Jan; 383(9914):304-5. PubMed ID: 24461117
    [No Abstract]   [Full Text] [Related]  

  • 15. Research on hormonal contraception and HIV.
    Cates W;
    Lancet; 2014 Jan; 383(9914):303-4. PubMed ID: 24461116
    [No Abstract]   [Full Text] [Related]  

  • 16. Research on hormonal contraception and HIV - Authors' reply.
    Ralph L; McCoy S; Hallett T; Padian N
    Lancet; 2014 Jan; 383(9914):305-6. PubMed ID: 24461119
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ; McCoy SI; Shiu K; Padian NS
    Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss associated with long-term use of depot medroxyprogesterone acetate.
    Lo SS; Fan SY;
    Hong Kong Med J; 2005 Dec; 11(6):491-5. PubMed ID: 16340026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early work on hormonal contraceptive use and HIV acquisition.
    Martin HL; Richardson BA; Mandaliya K; Achola JO; Overbaugh J; Kreiss JK
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S12-4. PubMed ID: 15867600
    [No Abstract]   [Full Text] [Related]  

  • 20. Study supports link between injectable hormonal contraceptive and HIV risk.
    Wise J
    BMJ; 2015 Jan; 350():h112. PubMed ID: 25575721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.